Category - Developments

Developments

RNA Disease Diagnostics stepwise protocol for molecular diagnosis of COVID-19 published in Nature Protocols

RNA Disease Diagnostics’ stepwise protocol for an RNA-extraction-free nano-amplified colorimetric test for COVID-19 was published in Nature Protocols. The test uses a unique dual-pronged molecular sensing approach that...

May 6, 2021

Developments

Profound Medical, Akumin in U.S. multi-center commercial pact for TULSA-PRO

Profound Medical (NASDAQ:PROF; TSX:PRN) signed a multi-site imaging center agreement for its TULSA-PRO device with Akumin (NASDAQ, TSX:AKU), a leading provider of freestanding, fixed-site outpatient diagnostic imaging...

May 6, 2021

Developments

Hepion Pharma completes patient recruitment in Phase 2a AMBITION trial of CRV431 in advanced NASH

Hepion Pharmaceuticals (NASDAQ:HEPA) completed recruitment for its Phase 2a AMBITION clinical trial, with all non-alcoholic steatohepatitis (NASH) patients in the 225 mg CRV431 dosing cohort now enrolled. After...

May 6, 2021

Developments

iBio and Fraunhofer USA conclude litigation and enter license agreement

iBio (NYSE American:IBIO) successfully resolved its lawsuit with Fraunhofer USA, confirming iBio’s ownership of certain intellectual property related to plant-based biopharmaceutical production. As part of the...

May 5, 2021

Developments

Hepion Pharma presents machine learning “learn and confirm” modeling strategy at NASH Congress

Hepion Pharmaceuticals (NASDAQ:HEPA) SVP of clinical pharmacology and analytics, Dr. Patrick Mayo, gave a virtual presentation entitled, “CRV431 – From Benchtop to Bedside Clinical Development” at the 4th Global NASH...

April 29, 2021

Developments

Three finalists named for 2021 Bloom Burton Award

Daniel Durocher, Ph.D., scientific co-founder of Repare Therapeutics; Carl Hansen, Ph.D., founder and CEO of AbCellera; and Hamed Shahbazi, chairman and CEO of WELL Health Technologies are the three finalists for the...

April 27, 2021

Developments

Seelos receives positive EMA orphan drug opinion for SLS-005 in ALS

Seelos Therapeutics (NASDAQ:SEEL) received a positive opinion on European orphan drug designation for SLS-005 in amyotrophic lateral sclerosis (ALS) from the EMA committee for orphan medicinal products. The positive...

April 20, 2021

Developments

Ripple Therapeutics treats first patient in DME, RVO Phase 2 trial

The first patient has been treated in Ripple Therapeutics’ RIPPLE-1 Phase 2 trial evaluating IBE-814 IVT, a proprietary intravitreal dexamethasone implant targeting inflammatory retinal diseases. RIPPLE-1 is a single...

April 20, 2021

Developments

MiMedx announces last patient visits in 3 late-stage musculoskeletal trials

MiMedx Group (NASDAQ:MDXG) announced that the last patients have completed their last clinical visits in two late-stage IND trials: Phase 3 studies of AmnioFix injectable as a potential treatment for plantar fasciitis...

April 19, 2021

Developments

TransMedics receives positive FDA advisory committee vote for OCS Heart System

The FDA’s Circulatory Systems Device Advisory Panel issued a favorable vote in support of approval of TransMedics Group’s (NASDAQ:TMDX) OCS Heart System to the FDA’s Office of Health Technology 2 (Cardiovascular...

April 7, 2021

Category - Developments

RNA Disease Diagnostics stepwise protocol for molecular diagnosis of COVID-19 published in Nature Protocols

Profound Medical, Akumin in U.S. multi-center commercial pact for TULSA-PRO

Hepion Pharma completes patient recruitment in Phase 2a AMBITION trial of CRV431 in advanced NASH

iBio and Fraunhofer USA conclude litigation and enter license agreement

Hepion Pharma presents machine learning “learn and confirm” modeling strategy at NASH Congress

Three finalists named for 2021 Bloom Burton Award

Seelos receives positive EMA orphan drug opinion for SLS-005 in ALS

Ripple Therapeutics treats first patient in DME, RVO Phase 2 trial

MiMedx announces last patient visits in 3 late-stage musculoskeletal trials

TransMedics receives positive FDA advisory committee vote for OCS Heart System

General

More